The combination of antifibrotic therapy and pulmonary vasodilator therapy improved transplant-free survival but had no significant impact on exercise capacity in pulmonary fibrosis and pulmonary ...
Forbes Health analyzed data from organizations including IHME, the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) to find the latest longevity statistics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results